title: Therapy-related CD7+ acute myeloid leukemia with trisomy 8 following acute monocytic leukemia.
abstract: We report a patient who developed CD7+ therapy-related acute myeloid leukemia (t-AML) with trisomy 8 after chemotherapy for AML.
authors.affiliation: First Department of Internal Medicine, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Tanaka
authors.forename: H
authors.initials: H
authors.lastname: Kanamori
authors.forename: S
authors.initials: S
authors.lastname: Yamaji
authors.forename: K
authors.initials: K
authors.lastname: Fujimaki
authors.forename: N
authors.initials: N
authors.lastname: Tomita
authors.forename: S
authors.initials: S
authors.lastname: Fujisawa
authors.forename: Y
authors.initials: Y
authors.lastname: Ishigatsubo
mesh_terms: D019011:Antigens, CD7 / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D002898:Chromosomes, Human, Pair 8 / Q000235:genetics; D003561:Cytarabine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000175:diagnosis / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000139:chemically induced* / Q000175:diagnosis / Q000235:genetics*; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis / Q000235:genetics*; D011239:Prednisolone / Q000627:therapeutic use; D014314:Trisomy / Q000235:genetics
chemical_list: D019011:Antigens, CD7; D014408:Biomarkers, Tumor; D003561:Cytarabine; D011239:Prednisolone; C015019:enocitabine; D015122:Mercaptopurine; D003630:Daunorubicin